Operations Excellence: BioPharma Operations Excellence - Survey indicates that biopharma is fully engaged in operations excellence, with an expanding role for suppliers. - BioPharm International

ADVERTISEMENT

Operations Excellence: BioPharma Operations Excellence
Survey indicates that biopharma is fully engaged in operations excellence, with an expanding role for suppliers.


BioPharm International


Survey participants were also asked about which cost elements are taken into consideration when calculating their overall equipment cost of ownership. Responses revealed that many significant cost components such as spare parts, consumables, and cost of failures, are not included by most companies in their overall cost evaluation and comparison.

Industry managers commented during panel discussions that there appears to be a growing acceptance of the valuable role a supplier can play in developing optimized product and service solutions. By following examples in other advanced industries such as the semiconductor industry, suppliers could become essential partners in developing biopharma processes and operational excellence. Wise partnership models would allow manufacturing companies to rely on the expertise suppliers have gained from working with various manufacturing companies and on their vast understanding of regulatory requirements.

For more information related to consortium activity or the biopharma survey, please visit Tefen's website http://www.tefen.com/ or e-mail

Amir London is a partner at Tefen Ltd, 1065 East Hillsdale Blvd, #421, Foster City, CA, 650.357.1120, ext. 115, fax: 650.372.1350,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here